OR4D9

Across TCGA pan-cancer cohorts, OR4D9 RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of OR4D9’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where OR4D9 RNA is repressed in tumor relative to normal tissue. In most cancer types OR4D9 is over-expressed in tumor, although a few such as KIRP show the opposite, repressed pattern.

KIRP are the cancer types where OR4D9 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in OR4D9 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRP	Male	All	−0.025	.023	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 1 strongest of 1 lineages.

OR4D9–KIRP

Open the KIRP breakdown →